{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T08:56:58Z","timestamp":1781081818920,"version":"3.54.1"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.jneuroim.2022.577956","type":"journal-article","created":{"date-parts":[[2022,8,28]],"date-time":"2022-08-28T01:15:57Z","timestamp":1661649357000},"page":"577956","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Presumptive isolated neurosarcoidosis involving eloquent structures: An argument for empirical TNF-\u03b1 inhibition"],"prefix":"10.1016","volume":"372","author":[{"given":"Lai Yin","family":"Law","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H.","family":"Barnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yael","family":"Barnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynette","family":"Masters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi N.","family":"Beadnall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd A.","family":"Hardy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen W.","family":"Reddel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2022.577956_bb0005","doi-asserted-by":"crossref","DOI":"10.1002\/ana.24582","article-title":"Discriminating long myelitis of neuromyelitis optica from sarcoidosis","volume":"79","author":"Flanagan","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2022.577956_bb0010","doi-asserted-by":"crossref","DOI":"10.1097\/00041327-200309000-00002","article-title":"Sarcoidosis of the anterior visual pathway: 24 new cases","author":"Frohman","year":"2003","journal-title":"J. Neuroophthalmol."},{"key":"10.1016\/j.jneuroim.2022.577956_bb0015","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000004644","article-title":"Infliximab for the treatment of CNS sarcoidosis: a multi-institutional series","volume":"89","author":"Gelfand","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2022.577956_bb0020","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000270","article-title":"Optic neuropathy associated with systemic sarcoidosis","volume":"3","author":"Kidd","year":"2016","journal-title":"Neurol. - Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.jneuroim.2022.577956_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2017.08.3408","article-title":"Clinical and imaging features of syphilic meningomyelitis: a case report and literature review","volume":"381","author":"Liu","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2022.577956_bb0030","doi-asserted-by":"crossref","DOI":"10.1111\/j.1442-9071.2009.02122.x","article-title":"Optic perineuritis secondary to Wegener\u2019s granulomatosis","volume":"37","author":"Purvin","year":"2009","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.jneuroim.2022.577956_bb0035","first-page":"119","article-title":"Optic perineuritis: clinical and radiographic features","author":"Purvin","year":"2001","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.jneuroim.2022.577956_bb0040","doi-asserted-by":"crossref","DOI":"10.3174\/ajnr.A3292","article-title":"Rim and flame signs: Postgadolinium MRI findings specific for non-CNS intramedullary spinal cord metastases, in","author":"Rykken","year":"2013","journal-title":"Am. J. Neuroradiol."},{"key":"10.1016\/j.jneuroim.2022.577956_bb0045","doi-asserted-by":"crossref","DOI":"10.3174\/ajnr.A1470","article-title":"Correlation of MR imaging findings and clinical manifestations in neurosarcoidosis","volume":"30","author":"Shah","year":"2009","journal-title":"Am. J. Neuroradiol."},{"key":"10.1016\/j.jneuroim.2022.577956_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2008.08.016","article-title":"Infliximab therapy rescues cyclophosphamide failure in severe central nervous system sarcoidosis","volume":"103","author":"Sodhi","year":"2009","journal-title":"Respir. Med."},{"key":"10.1016\/j.jneuroim.2022.577956_bb0055","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2018.2295","article-title":"Definition and consensus diagnostic criteria for neurosarcoidosis: from the neurosarcoidosis consortium consensus group","volume":"75","author":"Stern","year":"2018","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jneuroim.2022.577956_bb0060","doi-asserted-by":"crossref","DOI":"10.1111\/j.1552-6569.2003.tb00202.x","article-title":"MRI features of intramedullary spinal cord ependymomas","volume":"13","author":"Sun","year":"2003","journal-title":"J. Neuroimaging"},{"key":"10.1016\/j.jneuroim.2022.577956_bb0065","doi-asserted-by":"crossref","DOI":"10.1097\/WNO.0b013e318281b84d","article-title":"Transient optic perineuritis as the initial presentation of central nervous system involvement by pre-B cell lymphocytic leukemia","volume":"33","author":"Townsend","year":"2013","journal-title":"J. Neuroophthalmol."},{"key":"10.1016\/j.jneuroim.2022.577956_bb0070","doi-asserted-by":"crossref","DOI":"10.1111\/j.1552-6569.2006.00032.x","article-title":"Neuroimaging of tuberculous myelitis: analysis of ten cases and review of literature","author":"Wasay","year":"2006","journal-title":"J. Neuroimaging"},{"key":"10.1016\/j.jneuroim.2022.577956_bb0075","article-title":"Central nervous system sarcoidosis-diagnosis and management","volume":"92","author":"Zajicek","year":"1999","journal-title":"QJM - Month. J. Assoc. Phys."},{"key":"10.1016\/j.jneuroim.2022.577956_bb0080","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000002992","article-title":"Central canal enhancement and the trident sign in spinal cord sarcoidosis","volume":"87","author":"Zalewski","year":"2016","journal-title":"Neurology"}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572822001515?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572822001515?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:40:50Z","timestamp":1759048850000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572822001515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":16,"alternative-id":["S0165572822001515"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2022.577956","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Presumptive isolated neurosarcoidosis involving eloquent structures: An argument for empirical TNF-\u03b1 inhibition","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2022.577956","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"577956"}}